Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ: MIRM · IEX Real-Time Price · USD
43.33
+2.96 (7.33%)
At close: Jul 26, 2024, 4:00 PM
43.19
-0.14 (-0.32%)
After-hours: Jul 26, 2024, 7:55 PM EDT
Mirum Pharmaceuticals Market Cap
Mirum Pharmaceuticals has a market cap or net worth of $2.04 billion as of July 26, 2024. Its market cap has increased by 104.19% in one year.
Market Cap
2.04B
Enterprise Value
1.89B
1-Year Change
104.19%
Ranking
Category
Stock Price
$43.33
Market Cap Chart
Since July 18, 2019, Mirum Pharmaceuticals's market cap has increased from $304.00M to $2.04B, an increase of 571.80%. That is a compound annual growth rate of 46.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 1.90B | 38.27% |
| Dec 29, 2023 | 1.38B | 91.39% |
| Dec 30, 2022 | 719.00M | 47.13% |
| Dec 31, 2021 | 488.70M | 8.84% |
| Dec 31, 2020 | 449.00M | -20.35% |
| Dec 31, 2019 | 563.70M | 85.43% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Akero Therapeutics | 1.96B |
| LeMaitre Vascular | 1.94B |
| Warby Parker | 1.93B |
| NeoGenomics | 1.93B |
| Ligand Pharmaceuticals | 1.90B |
| Harmony Biosciences Holdings | 1.89B |
| Zai Lab | 1.87B |
| Kiniksa Pharmaceuticals | 1.84B |